MedTrace Logo

Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients

NCT01951430 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 229

Last updated 2021-09-13

No results posted yet for this study

Summary

The purpose of this study is to observe the number of new cases of infections per population in a given time period and their characteristics in a pathology (myelodysplastic syndrome, MDS)that involves ineffective production (or dysplasia) of a class of blood cells.

Conditions

Interventions

DRUG

Antibiotic and antifungal drugs

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Livio Pagano, Dr. · Università Cattolica del Sacro Cuore - Policlinico A. Gemelli - Roma

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2020-10-29
Completion
2020-10-29

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01951430 on ClinicalTrials.gov